Pfizer: 3 Key Risks That Warrant A Sell (NYSE:PFE)
1. Pfizer's recent drug trials show promising efficacy against various diseases. 2. Recent FDA approvals may enhance Pfizer’s revenue potential significantly. 3. Increased competition in the pharmaceutical market could affect Pfizer's market share. 4. Analysts predict potential growth leading to an upward price trajectory for PFE.